These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 200754)

  • 1. Leukocyte migration in ovarian carcinoma: comparison of inhibitory activity of tumor extracts.
    Faiferman I; Gleicher N; Cohen CJ; Koffler D
    J Natl Cancer Inst; 1977 Dec; 59(6):1593-7. PubMed ID: 200754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on xenogenic antisera to tumor-associated antigen of ovarian carcinoma.
    Gerber MA; Faiferman I; Cohen CJ; Koffler D
    Clin Immunol Immunopathol; 1977 Sep; 8(2):171-80. PubMed ID: 198173
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
    Nakamura S
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity in patients with ovarian carcinoma.
    Chen SY; Koffler D; Cohen CJ
    Am J Obstet Gynecol; 1973 Feb; 115(4):467-70. PubMed ID: 4346615
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
    Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Density distribution and antigenic characterization of cell subpopulations isolated from cystic fluids of ovarian serous neoplasms.
    Harłozińska A; Bar JK; Rabczyński J; Noworolska A; Richter R; Cisło M
    Anticancer Res; 1989; 9(1):161-6. PubMed ID: 2705745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between carcinoembryonic antigen content of tumor extracts and leukocyte migration reactivity of tumor patients.
    Matzku S; Zöller M; Schulz U; Dietze W; Barth HO; Saeger HD; Price MR
    J Natl Cancer Inst; 1980 Jun; 64(6):1345-8. PubMed ID: 6929372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human leukocyte migration in agar by 3-M potassium chloride extracts of stomach, colon, and lung cancers.
    Iwaki J; Akagi M; Sairenji T; Hinuma Y
    J Natl Cancer Inst; 1979 Jul; 63(1):5-10. PubMed ID: 286834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-specific leucocyte migration inhibition of gynaecological carcinoma patients.
    Tosner J; Fixa B
    Clin Exp Immunol; 1979 Nov; 38(2):356-60. PubMed ID: 527267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian tumor antigens: preliminary histological investigation.
    Daunter B; Jaa-Kwee D; Miklosi S; Wright G
    Gynecol Oncol; 1986 Mar; 23(3):364-70. PubMed ID: 3514391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
    Schmeisser G; Kademann J
    Arch Geschwulstforsch; 1980; 50(2):169-72. PubMed ID: 7436701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte migration inhibition by soluble extracts of MCF-7 tissue culture cell line derived from breast carcinoma.
    McCoy JL; Jerome LF; Anderson C; Cannon GB; Alford TC; Connor RJ; Oldham RK; Herberman RB
    J Natl Cancer Inst; 1976 Nov; 57(5):1045-9. PubMed ID: 1003541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of leukocyte migration in agar by soluble extract from a human ovarian carcinoma cell line.
    Sekiguchi M; Shibusawa M; Asanuma K; Kaku R; Wagatsuma T; Kobayashi H; Fujii G
    Jpn J Exp Med; 1982 Jun; 52(3):119-24. PubMed ID: 7131857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterophile antigens in serous cystadenocarcinoma of the human ovary.
    Kamada M; Mori T; Sakamoto Y; Daitoh T; Furumoto H; Irahara M; Aono T; Mori T
    Asia Oceania J Obstet Gynaecol; 1992 Dec; 18(4):387-95. PubMed ID: 1283511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human leukocyte migration in agarose by kcl extracts of carcinoma of the lung.
    Boddie AW; Holmes EC; Roth JA; Morton DL
    Int J Cancer; 1975 May; 15(5):823-9. PubMed ID: 1140874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte migration inhibition in patients with Ewing's sarcoma by 3-M potassium chloride extracts of fresh and tissue-cultured Ewing's sarcomas.
    McCoy JL; Jerome LJ; Cannon GB; Pomeroy TC; Connor RJ; Oldham RK; Weese JL; Herberman RB
    J Natl Cancer Inst; 1977 Oct; 59(4):1119-25. PubMed ID: 903991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leukocyte migration inhibition in women with tumors in an environment with ovarian carcinoma antigen and encephalitogenic factor].
    Tosner J; Fixa B
    Cas Lek Cesk; 1984 Mar; 123(12):354-7. PubMed ID: 6085556
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification of soluble hepatocellular carcinoma extracts.
    Lee CS; Chuang CY; Lin FY; Lin TY
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Sep; 12(3):81-5. PubMed ID: 232674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.